"Emergency rooms are very good at treating and stabilizing many serious health issues, but unfortunately they are not equipped with imaging equipment nor ophthalmology expertise to quickly assess sight-threatening conditions." Pravin Dugel, MD, physician executive director at Banner – University Medical Center Phoenix Eye Institute and managing partner at Retinal Consultants of Arizona, said in a statement. "Sight is one of life's precious gifts, and it can be seriously impaired or stolen from us due to trauma or disease," Dr. Paxos, which uses an FDA Class II-registered adapter to capture images, has enabled Banner Health to launch an ophthalmology program that enables ER doctors to send images of serious eye injuries or disorders to specialists. San Francisco-based DigiSight Technologies, a developer of telehealth tools for healthcare teams, has launched its telehealth collaboration tool, Paxos, at 13 Banner Health facilities across Arizona. Fit4D coaches will bring the human element to Glooko’s mobile app, helping users access additional motivation and education. The pairing will give Fit4D’s coaches access to Glooko’s device-agnostic platform, which people with diabetes see in the form of a mobile app they can use to automatically sync their blood glucose data from nearly all types of blood glucose meters, CGMs and insulin pumps. The pancreas responds by producing greater amounts of insulin, to try and achieve some degree of management of blood glucose.Īs insulin overproduction occurs over a very long period of time, the insulin-producing cells in the pancreas wear themselves out, so that by the time someone is diagnosed with T2D, they have lost 50–70% of their insulin-producing cells.New York-based Fit4D, which offers digital coaching for people with diabetes, is partnering with global diabetes data management company Glooko to bring a more data-driven approach to their mobile patient engagement tools. During this time insulin resistance starts, because the insulin is increasingly ineffective at managing blood glucose levels. Examining the data by super-region, North Africa and the Middle East had the highest rate at 39.4% in this age group, while Central Europe, Eastern Europe, and Central Asia had the lowest rate at 19.8%.Īlmost all global cases (96%) are Type 2 diabetes (T2D).ĭA says Type 2 diabetes develops over a long period of time (years). The highest rate was 24.4% for those between ages 75 and 79. The Lancet says diabetes was especially evident in people 65 and older in every country and recorded a prevalence rate of more than 20% for that demographic worldwide.
The annual cost of the condition is forecast to grow to about $45 billion per annum in this time.” “If the growth rates of the past decade continue, there will be more than 3.1 million Australians, around 8.3% of the projected population, living with diabetes by 2050.
“In the past 20 years, the numbers have dramatically increased from 459,678 people living with the condition in 2000 to more than 1.47 million in 2022, an increase of around 220%,” DA says in Change the Future, a report calling for health care reform. The rate in Latin America and the Caribbean is projected to increase to 11.3%.ĭiabetes Australia (DA) predicts incidence in this country will rise above 8%. The highest rate is 9.3% in North Africa and the Middle East, and that number is projected to jump to 16.8% by 2050. It says the current global prevalence rate is 6.1%, making diabetes one of the top 10 leading causes of death and disability. More than half a billion people are living with diabetes worldwide, and that number is projected to more than double to 1.3 billion people in the next 30 years, with every country seeing an increase, according to a new report in the influential British medical journal The Lancet. Researchers are forecasting a massive increase in the number of people worldwide affected by diabetes.
0 kommentar(er)
